C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/03/2002	US20020142978 Synergistic improvements to polynucleotide vaccines
10/03/2002	US20020142965 Administering to animal peptide wherein the amino acid sequence of peptide comprises the carboxyl-terminal sequence of a growth hormone, and wherein said peptide is not the intact, full-length growth hormone
10/03/2002	US20020142964 Single-chain polypeptides
10/03/2002	US20020142963 Methods for increasing bone formation and enhancing bone accretion
10/03/2002	US20020142961 As pharmaceuticals, diagnostics, biosensors and bioreactors
10/03/2002	US20020142960 Exposing cells to an aggregate formulation which comprises VP22, or a polypeptide with transport function of VP22, and oligonucleotides or polynucleotides; exposing cells to a disaggregating agent which can promote disaggregation
10/03/2002	US20020142957 May be used in vaccines and drugs for prophylaxis and therapy
10/03/2002	US20020142954 Laminin 15 and uses thereof
10/03/2002	US20020142953 Materials and methods relating to lipid metabolism
10/03/2002	US20020142952 Polynucleotides encoding novel secreted proteins
10/03/2002	US20020142951 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
10/03/2002	US20020142949 Inducing cytotoxicity in a neoplastic cell comprising: contacting said cell with an amount of a GSSP-2 polypeptide
10/03/2002	US20020142939 HMGI proteins in cancer and obesity
10/03/2002	US20020142938 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/03/2002	US20020142844 Biometric broadband gaming system and method
10/03/2002	US20020142468 Interfering with fungal gene expression; obtain fungal sample, incubate with modulator, monitor transcription and propagation of fungal structures
10/03/2002	US20020142467 Method for culturing recombinant cells
10/03/2002	US20020142466 Controlling ciliary neurotrophic factor cell signaling; obtain cell, incubate with modulator, monitor cell signaling activity
10/03/2002	US20020142464 Nucleotide sequences coding preferential polypeptide for use in the treatment of infections, atherosclerosis, cancer, nervous system, gastrointestinal, muscle, bone, heart, vision, kidney and urogenital disorders
10/03/2002	US20020142461 T1 Receptor-like ligand II and uses thereof
10/03/2002	US20020142456 Protein for use in the treatment of body weight defects
10/03/2002	US20020142448 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer
10/03/2002	US20020142445 Peptides for use in the treatment of tumors and graft versus host disease
10/03/2002	US20020142444 AL-2 neurotrophic factor
10/03/2002	US20020142443 Polypeptide for use in the diagnosis, treatment and prevention of cell proliferative and apoptosis disorders
10/03/2002	US20020142442 Tumor suppressor WAF1
10/03/2002	US20020142441 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/03/2002	US20020142436 Enzymatic protein for use in the treatment of tumors, nervous system, cardiovascular, psychological, pregnancy, bone, kidney, respiratory and alimentary canal disorders
10/03/2002	US20020142432 Human endosulfine gene
10/03/2002	US20020142431 Polypeptide for use in the treatment infections, osteoporosis, stroke, reperfusion injuries, nervous system, liver, vision, brain, blood, heart disorders
10/03/2002	US20020142424 Protein for use as a bioluminescent signaling tool
10/03/2002	US20020142422 Nucleotide sequences coding metabolic pathway protein for use in foods, feed, cosmetics and pharmaceutical
10/03/2002	US20020142421 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
10/03/2002	US20020142420 Cloned leptospira outer membrane protein
10/03/2002	US20020142418 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/03/2002	US20020142417 Antioxidant protein 2, gene and methods of use therefor
10/03/2002	US20020142415 Novel polypeptides and polynucleotides and methods of using them
10/03/2002	US20020142414 Nucleotide sequences coding polypeptide for use in the treatment of lung defects, septic shock or inflammation
10/03/2002	US20020142404 Nucleotide sequences coding polypeptide for use in generation of amino acids for use in human medicine, foods, and animal nutrients
10/03/2002	US20020142398 Chemokine expressed in fetal spleen, its production and uses
10/03/2002	US20020142396 Nucleotide sequences coding polypeptide for use in the treatment of cancer
10/03/2002	US20020142395 Proteins for use in the treatment of tumor, arthritis and vision defects
10/03/2002	US20020142394 Exonuclease-mediated gene assembly in directed evolution
10/03/2002	US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA
10/03/2002	US20020142391 Synthesis of human procollagens and collagens in recombinant DNA systems
10/03/2002	US20020142390 Nitrogen transport metabolism
10/03/2002	US20020142389 Soluble T cell receptor
10/03/2002	US20020142388 Bacterial host strains
10/03/2002	US20020142387 Methods for producing protein domains and analyzing three dimensional structures of proteins by using said domains
10/03/2002	US20020142385 Peptide for use in treatment of vision defcets
10/03/2002	US20020142384 Generating soluble active recombinat proteins; obtain vector, insert preferential binding domain into vector, transform cell, propagate induce expresion of recombinant protein
10/03/2002	US20020142383 Isolated nucleic acid molecules encoding human transport proteins
10/03/2002	US20020142382 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
10/03/2002	US20020142381 Peptide for use in human therapeutics and diagnostics
10/03/2002	US20020142380 Polypeptide for use in the treatment of stroke, retinopathy, reperfusion injuries, cachexia, immunological, nervous system, liver, bone, viral disorders
10/03/2002	US20020142378 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/03/2002	US20020142377 18607, a novel human calcium channel
10/03/2002	US20020142376 Peptide for use in the diagnosis and treatment of nervous system disorders
10/03/2002	US20020142375 Nucleotide sequences coding G protein coupled receptors for use in the diagnosis and treatment of cancer, adult respiratory distress, nervous system disorders and arthritis
10/03/2002	US20020142373 Tissue factor protein variants
10/03/2002	US20020142372 Fragments of cr1 and their use
10/03/2002	US20020142371 Detecting target polynucleotides in a test sample; obtain sample, incubate with probe, detect signal, presence of signal indicates target sequences
10/03/2002	US20020142363 Medical diagnosis, therapy; detecting binding of proteins
10/03/2002	US20020142359 Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system
10/03/2002	US20020142357 TNF receptor action modulation
10/03/2002	US20020142353 Connective tissue growth factor (CTGF) and methods of use
10/03/2002	US20020142352 Novel ectoparasite salvia proteins and apparatus to collect such proteins
10/03/2002	US20020142350 Viral nucleotide sequences for use in the prevention and treatment of viral diseases
10/03/2002	US20020142348 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction
10/03/2002	US20020142346 Binding compounds and methods for identifying binding compounds
10/03/2002	US20020142330 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
10/03/2002	US20020142324 Preparing clonal library of genetically engineered nucleotide sequences; obtain nucleotide sequences, incubate with vector and enzyme, seal nucleotide sequences into vector, transform cells, recover clonal library
10/03/2002	US20020142319 Expressed sequences of Arabidopsis thaliana
10/03/2002	US20020142312 Nucleotide sequences coding receptor protein for use in the diagnosis and treatment of addictive, nervous system and psychological disorders
10/03/2002	US20020142309 Nucleic acid hairpin probes and uses thereof
10/03/2002	US20020142303 Diagnosing schizophrenia in humans; obtain bodily fluid, electrophoresis, detect protein isoform, compare to control, evaluate for schizophrenia
10/03/2002	US20020142302 Novel nucleic acids and polypeptides
10/03/2002	US20020142299 PTD-modified proteins
10/03/2002	US20020142298 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/03/2002	US20020142292 Mammalian genes; related reagents and methods
10/03/2002	US20020142284 Detecting kidney protective agent; obtain cells, incubate with modulator, measure nucleotide sequence expression, compare to control, monitor adjustment in nucleotide sequences expresion
10/03/2002	US20020142008 Immunogenic pili presenting foreign peptides, their production and use
10/03/2002	US20020142006 Chimeric nontoxic mutants of enterotoxins as mucosal adjuvants for cell-mediated or humoral immunity
10/03/2002	US20020142004 Immunoreactive and immunotherapeutic molecules
10/03/2002	US20020142003 Tumor-associated antigen (B345)
10/03/2002	US20020142002 Anthrax
10/03/2002	US20020142001 DNA immunization against Chlaymdia infection
10/03/2002	US20020142000 Genetic engineering
10/03/2002	US20020141999 Complexing; immunoassay, immunotherapy
10/03/2002	US20020141996 Methods of treating infections with chimeric anti-TNF antibodies
10/03/2002	US20020141993 Apoptosis; anticancer agents
10/03/2002	US20020141985 Dietetics, eating disorders, antidiabetic agents
10/03/2002	US20020141984 Screening tests
10/03/2002	US20020141983 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
10/03/2002	US20020141979 Antidiabetic agents; prevent organ rejection; antiinflammatory agents
10/03/2002	US20020141975 Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
10/03/2002	US20020141974 Hepatitis therapeutics
10/03/2002	US20020141970 Stabilized with chelate compound; storage stability
10/03/2002	US20020141941 PSCA: prostate stem cell antigen and uses thereof
10/03/2002	CA2664797A1 Cytotoxic factors for modulating cell death

1 ... 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 ... 2916